Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent [Phase 1]
Phase 1 trial of activated T-cell therapy with low-dose aldesleukin and sargramostim for advanced ovarian, fallopian tube, or primary perito…
-
CLINICAL_TRIALS withdrawal · 2015-12-23Clinical Trial Update: BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients [Phase 1, Phase 2]
The Phase 1/2 clinical trial of BNC105P in partially platinum-sensitive ovarian cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer [NA]
A clinical trial evaluating celecoxib for pain, weight loss, and weakness in advanced cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-28Clinical Trial Update: Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer [Phase 4]
A Phase 4 clinical trial evaluating MRI for lymph node staging in ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-18Clinical Trial Update: Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study
A 27-year population-based study analyzes trends in incidence and survival for ovarian germ cell tumors. The associated clinical trial NCT00…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-06-18Clinical Trial Update: Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass
A clinical trial evaluating the prediction of ovarian malignancy in the presence of a sonographic pelvic mass has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-11Clinical Trial Update: Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial of Tai-chi / Qi-gong for gynecologic cancers has been withdrawn; the study targeted ovarian cancer and primary peritoneal …
-
CLINICAL_TRIALS withdrawal · 2015-06-01Clinical Trial Update: Research Study in Patients With Advanced Ovarian Epithelial Cancer
A Gynecologic Oncology Group trial in advanced ovarian epithelial cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-18Clinical Trial Update: Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer [NA]
A clinical trial evaluating prolonged Emend (aprepitant) in combination with oxaliplatin and topotecan for previously treated ovarian cancer…
-
CLINICAL_TRIALS withdrawal · 2015-03-18Clinical Trial Update: Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression [Phase 1]
A Phase 1 feasibility study of fondaparinux (Arixtra) in chemotherapy-pretreated ovarian cancer patients at high risk of progression has bee…
-
CLINICAL_TRIALS withdrawal · 2014-12-31Clinical Trial Update: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy [Phase 3]
A Phase 3 trial of Acetyl-L-Carnitine hydrochloride to prevent chemotherapy-induced peripheral neuropathy in patients with recurrent ovarian…
-
CLINICAL_TRIALS withdrawal · 2014-11-11Clinical Trial Update: Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca [NA]
The trial investigating intravenous and intraperitoneal chemotherapy with abdominal hyperthermia for ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-09-17Clinical Trial Update: Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin [Phase 2]
A Phase 2 trial evaluating JX-594 for peritoneal carcinomatosis of ovarian cancer origin has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-06Clinical Trial Update: A Prospective Trial of COXEN Chemotherapy Prediction [NA]
A prospective trial of COXEN chemotherapy prediction sponsored by the University of Virginia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-12-20Clinical Trial Update: Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
A Phase 2 safety and efficacy study of gemcitabine plus bevacizumab for platinum-resistant ovarian, fallopian tube, or primary peritoneal ca…
-
CLINICAL_TRIALS withdrawal · 2013-09-05Clinical Trial Update: FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer [Phase 2]
Phase 2 trial of FR901228 for relapsed or refractory advanced ovarian epithelial cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-22Clinical Trial Update: Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy [NA]
The trial evaluating celecoxib to prevent ovarian cancer in BRCA1/BRCA2 mutation carriers undergoing prophylactic oophorectomy has been with…
-
CLINICAL_TRIALS withdrawal · 2013-08-14Clinical Trial Update: Comparison of Standard of Care or Treatment on Protocol [NA]
A terminated clinical trial (NCT01010334) comparing standard of care versus a protocol treatment. The study covers several cancers, includin…
-
CLINICAL_TRIALS withdrawal · 2013-08-05Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer [Phase 1]
Phase 1 cancer vaccine trial for metastatic or recurrent cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-05Clinical Trial Update: CA-125 in Screening Patients at High Risk for Ovarian Cancer
Clinical trial evaluating CA-125 screening for women at high risk of ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-24Clinical Trial Update: Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity [Phase 1]
A Phase 1 study examining whole-abdomen radiation with intraperitoneal chemotherapy for small-volume recurrent ovarian cancer limited to the…
-
CLINICAL_TRIALS withdrawal · 2013-07-09Clinical Trial Update: Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial of nitrocamptothecin for recurrent or metastatic ovarian cancer and primary peritoneal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-06-10Clinical Trial Update: Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172 [NA]
Withdrawn clinical trial update for GOG-172 evaluating paclitaxel plus cisplatin in stage III ovarian cancer. No results or economic outcome…
-
CLINICAL_TRIALS withdrawal · 2013-06-10Clinical Trial Update: Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin [Phase 2]
A Phase 2 trial of gemcitabine and carboplatin for persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peri…
-
CLINICAL_TRIALS withdrawal · 2012-12-27Clinical Trial Update: PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion [NA]
Clinical trial NCT00173407 investigating PTEN and IGFBP-3 correlation in ovarian cancer invasion has been withdrawn.